Changes in EPA and DHA during supplementation with omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

被引:0
|
作者
Myhre, P. [1 ]
Smith, E. B. [2 ]
Kalstad, A. A. [3 ]
Tveit, S. [1 ]
Laake, K. [3 ]
Smith, P. [1 ]
Nilsen, D. W. T. [4 ]
Tveit, A. [5 ]
Solheim, S. [3 ]
Arnesen, H. [3 ]
Seljeflot, I. [3 ]
机构
[1] Akershus Univ Hosp, Div Med, Akershus, Norway
[2] Aalborg Univ Hosp, Aalborg, Denmark
[3] Oslo Univ Hosp Ulleval, Oslo, Norway
[4] Stavanger Univ Hosp, Stavanger, Norway
[5] Baerum Hosp, Dept Med Res, Baerum, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2429 / 2429
页数:1
相关论文
共 50 条
  • [21] A meta-analysis of trials of Omega-3 fatty acids supplementation in cardiovascular diseases
    Marchioli, R.
    Marfisi, R.
    Doval, H.
    Varini, S.
    Nul, D.
    Grancelli, H.
    Comignani, P. D.
    Fuselli, J. J.
    Tognoni, G.
    CIRCULATION, 2008, 118 (12) : E260 - E260
  • [22] Supplementation with EPA and DHA omega-3 fatty acids improves peripheral immune cell mitochondrial dysfunction and inflammation in subjects with obesity
    Borja-Magno, Angelica I.
    Furuzawa-Carballeda, Janette
    Guevara-Cruz, Martha
    Arias, Clorinda
    Granados, Julio
    Bourges, Hector
    Tovar, Armando R.
    Sears, Barry
    Noriega, Lilia G.
    Gomez, Francisco Enrique
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2023, 120
  • [23] ] No Cardiovascular Protection From Omega-3 Fatty Acids
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (16): : 1631 - 1631
  • [24] Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
    Myhre, Peder L.
    Berge, Trygve
    Kalstad, Are A.
    Tveit, Sjur H.
    Laake, Kristian
    Schmidt, Erik B.
    Solheim, Svein
    Arnesen, Harald
    Selje, Ingebjorg
    Tveit, Arnljot
    CLINICAL NUTRITION, 2023, 42 (09) : 1657 - 1660
  • [25] Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events
    Markozannes, Georgios
    Ntzani, Evangelia E.
    Tsapas, Apostolos
    Mantzoros, Christos S.
    Tsiara, Stavroula
    Xanthos, Theodoros
    Karpettas, Nikos
    Patrikios, Ioannis
    Rizos, Evangelos C.
    CLINICAL NUTRITION, 2022, 41 (04) : 923 - 930
  • [26] Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease
    Yong Cao
    Lei Lu
    Jun Liang
    Min Liu
    Xianchi Li
    RongRong Sun
    Yi Zheng
    Peiying Zhang
    Cell Biochemistry and Biophysics, 2015, 72 : 77 - 81
  • [27] Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases
    Tutor, Austin
    O'Keefe, Evan L.
    Lavie, Carl J.
    Elagizi, Andrew
    Milani, Richard
    O'Keefe, James
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 84 : 19 - 26
  • [28] Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
    Abdelhamid, Asmaa S.
    Brown, Tracey J.
    Brainard, Julii S.
    Biswas, Priti
    Thorpe, Gabrielle C.
    Moore, Helen J.
    Deane, Katherine Ho
    Summerbell, Carolyn D.
    Worthington, Helen V.
    Song, Fujian
    Hooper, Lee
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (03):
  • [29] The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease
    Lee, KW
    Lip, GYH
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (07) : 465 - 480
  • [30] Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease
    Cao, Yong
    Lu, Lei
    Liang, Jun
    Liu, Min
    Li, Xianchi
    Sun, RongRong
    Zheng, Yi
    Zhang, Peiying
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (01) : 77 - 81